RenovaCare, Inc. (OTCMKTS:RCAR) Sees Significant Increase in Short Interest

RenovaCare, Inc. (OTCMKTS:RCARGet Rating) was the recipient of a significant increase in short interest during the month of December. As of December 30th, there was short interest totalling 2,800 shares, an increase of 27.3% from the December 15th total of 2,200 shares. Based on an average daily trading volume, of 19,000 shares, the days-to-cover ratio is currently 0.1 days.

RenovaCare Stock Up 16.8 %

Shares of RenovaCare stock opened at $0.07 on Friday. The firm has a market cap of $6.11 million, a P/E ratio of -1.17 and a beta of 1.48. RenovaCare has a fifty-two week low of $0.01 and a fifty-two week high of $0.39. The business has a 50-day moving average price of $0.04 and a 200 day moving average price of $0.05.

About RenovaCare

(Get Rating)

RenovaCare, Inc operates as a development stage company, which engages in the research, development, and commercialization of autologous cellular therapies that can be used for medical and aesthetic applications. Its flagship technology is the CellMist System, which is a treatment methodology for cell isolation for the regeneration of human skin cells and other tissues, and a solution sprayer device for delivering cells to the treatment area.

Featured Articles

Receive News & Ratings for RenovaCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RenovaCare and related companies with MarketBeat.com's FREE daily email newsletter.